[1] Kennedy LB, Salama AKS.A review of cancer immunotherapy toxicity[J]. CA Cancer J Clin, 2020, 70(2): 86-104.
[2] Jin KT, Wang SB, Ying XJ, et al.Immune-mediated adverse effects of immune-checkpoint inhibitors and their management in cancer[J]. Immunol Lett, 2020, 221: 61-71.
[3] Schneider BJ, Naidoo J, Santomasso BD, et al.Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update[J]. J Clin Oncol, 2021, 39(36): 4073-4126.
[4] Ahmadzadeh M, Johnson LA, Heemskerk B, et al.Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired[J]. Blood, 2009, 114(8): 1537-1544.
[5] 郑雅丹,李岭,庞智. 免疫检查点抑制剂及其相关性结肠炎的研究进展[J]. 胃肠病学,2020,25(1):51-54.
[6] Takahashi Y, Nagaya T, Iwaya Y, et al.CD8+ Lymphocyte Infiltration Is a Specific Feature of Colitis Induced by Immune Checkpoint Inhibitors[J]. Dig Dis Sci, 2023, 68(2): 451-459.
[7] Luoma AM, Suo S, Williams HL, et al.Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy[J]. Cell, 2020, 182(3): 655-671.
[8] Thompson JA, Schneider BJ, Brahmer J, et al.Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2022, 20(4): 387-405.
[9] Li Y, Kang X, Wang H, et al.Clinical diagnosis and treatment of immune checkpoint inhibitor-associated adverse events in the digestive system[J]. Thorac Cancer, 2020, 11(4): 829-834. |
